These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 9187424

  • 1. Long-term pulmonary sequelae after treatment of childhood Hodgkin's disease.
    Bossi G, Cerveri I, Volpini E, Corsico A, Baio A, Corbella F, Klersy C, Arico M.
    Ann Oncol; 1997; 8 Suppl 1():19-24. PubMed ID: 9187424
    [Abstract] [Full Text] [Related]

  • 2. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
    Villani F, Busia A, Villani M, Laffranchi A, Viviani S, Bonfante V.
    Anticancer Res; 2009 Feb; 29(2):777-83. PubMed ID: 19331235
    [Abstract] [Full Text] [Related]

  • 3. Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy.
    Mefferd JM, Donaldson SS, Link MP.
    Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):679-85. PubMed ID: 2466027
    [Abstract] [Full Text] [Related]

  • 4. Assessment of cardiac and pulmonary function in adult patients with Hodgkin's disease treated with ABVD or MOPP/ABVD plus adjuvant low-dose mediastinal irradiation.
    Salloum E, Tanoue LT, Wackers FJ, Zelterman D, Hu GL, Cooper DL.
    Cancer Invest; 1999 Mar; 17(3):171-80. PubMed ID: 10099655
    [Abstract] [Full Text] [Related]

  • 5. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
    Arranz R, Gil-Fernández JJ, Muñoz E, Acevedo A, Sobrino MP, Fernández-Rañada JM.
    Sangre (Barc); 1998 Jun; 43(3):179-84. PubMed ID: 9741222
    [Abstract] [Full Text] [Related]

  • 6. Long-term follow-up of survival in Hodgkin's lymphoma.
    Canellos GP, Niedzwiecki D, Johnson JL.
    N Engl J Med; 2009 Dec 10; 361(24):2390-1. PubMed ID: 20007568
    [No Abstract] [Full Text] [Related]

  • 7. Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy).
    De Lena M, Ditonno P, Lorusso V, Timurian A, Pellecchia A, Brandi M, Berardi F, Marzullo F.
    Haematologica; 1993 Dec 10; 78(4):230-5. PubMed ID: 7507457
    [Abstract] [Full Text] [Related]

  • 8. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y, Shi YK, He XH, Feng FY, Zhou LQ, Gu DZ.
    Zhonghua Zhong Liu Za Zhi; 2008 Aug 10; 30(8):630-4. PubMed ID: 19102946
    [Abstract] [Full Text] [Related]

  • 9. Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.
    Busia A, Laffranchi A, Viviani S, Bonfante V, Villani F.
    Anticancer Res; 2010 Oct 10; 30(10):4381-7. PubMed ID: 21036768
    [Abstract] [Full Text] [Related]

  • 10. Treatment of childhood Hodgkin's disease without radiotherapy.
    van den Berg H, Zsiros J, Behrendt H.
    Ann Oncol; 1997 Oct 10; 8 Suppl 1():15-7. PubMed ID: 9187423
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of childhood Hodgkin's disease with chemotherapy alone. Experiences from the Royal Children's Hospital, Melbourne.
    Ekert H.
    Cancer Treat Res; 1989 Oct 10; 41():241-6. PubMed ID: 2484293
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
    Valagussa P, Bonadonna G.
    Haematologica; 1998 Sep 10; 83(9):769-70. PubMed ID: 9825571
    [No Abstract] [Full Text] [Related]

  • 16. An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV Hybrid program.
    Klimo P, Connors JM.
    Semin Hematol; 1988 Apr 10; 25(2 Suppl 2):34-40. PubMed ID: 2456621
    [Abstract] [Full Text] [Related]

  • 17. Late pulmonary toxicity after treatment for Hodgkin's disease.
    Villani F, De Maria P, Bonfante V, Viviani S, Laffranchi A, Dell'oca I, Dirusso A, Zanini M.
    Anticancer Res; 1997 Apr 10; 17(6D):4739-42. PubMed ID: 9494599
    [Abstract] [Full Text] [Related]

  • 18. Avascular necrosis of the femoral head after treatment of Hodgkin's disease.
    Tombolini V, Capua A, Pompili E.
    Acta Oncol; 1992 Apr 10; 31(1):64-5. PubMed ID: 1375043
    [No Abstract] [Full Text] [Related]

  • 19. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S, Camós M, López-Guillermo A, Bosch F, Cervantes F, Blandé J, Esteve J, Cobo F, Nomdedeu B, Campo E, Montserrat E.
    Cancer; 2000 May 01; 88(9):2142-8. PubMed ID: 10813727
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.